缓解的道路:在2型炎症疾病中不断发展的治疗概念
Marek Lommatzsch1, Katharina Blumchen2, Lisa A Beck3
1Department of Pneumology and Intensive Care Medicine, University of Rostock, Germany.
2型炎症非传染性疾病 (NCDs) 的管理正在转向缓解. 这种在喘中先进的新范式,使用向疗法来修改疾病的进展.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和临床免疫学
- 肺部病理学 肺部病理学
背景情况:
- 以2型炎症为特征的非传染性疾病 (NCD),如喘和亚托邦性皮肤炎,在全球范围内正在增加.
- 管理这些疾病的模式正在发生转变,重点是疾病的修饰和实现缓解.
- 缓解的概念最初应用于非2型炎症性疾病,如类风湿性关节炎,现在正在被用于2型炎症性疾病.
研究的目的:
- 审查缓解的演变作为2型炎症疾病的治疗目标.
- 讨论推动这种新范式的潜在病理生理学和治疗进步.
- 确定挑战和未来的研究方向,以实现2型炎性非传染性疾病的缓解.
主要方法:
- 对2型炎症和疾病缓解研究的文献综述.
- 分析2型炎症疾病的病理生理学.
- 评估针对2型途径的现有和新兴疗法.
主要成果:
- 缓解的概念是新的,但在2型炎症疾病中,喘最先进.
- 更好地了解2型炎症的病理生理学支持疾病的修饰.
- 高效的药物选择性向2型途径,使这种新的治疗方法成为可能.
结论:
- 达到缓解意味着在管理2型炎症性非传染性疾病方面取得了重大进展.
- 需要进一步的研究来应对挑战并优化缓解策略.
- 转向缓解的范式转变有望改善慢性炎症疾病患者的治疗结果.
更多相关视频
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
